Henry Fernandez steps down as Lead Independent Director of Royalty Pharma board

Royalty Pharma plc

Fernandez resigned effective August 13, 2025, after five years on the board.
No disagreement with the company; departure is voluntary.
Board thanks Fernandez for his service and contributions.
Company intends to name a new Lead Independent Director in the near future.

item 5.02 item 9.01

Royalty Pharma plc filing history →

Source: SEC EDGAR

accession 0001193125-25-179892

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.